Home / Research / Clearances / K120397 Public FDA record
K120397: MEB-2300A NEUROPACK EVOKED POTENTIAL AND EMG MEASURING SYSTEM 510(k) clearance K120397 for Nihon Kohden Corp.. View source facts, labeled dates, and the original FDA record.
FDA identifier K120397
Company in FDA record Nihon Kohden Corp.
FDA decision date Sep 19, 2012
First observed by MedTech Watch Nov 16, 2026
Latest observed content change Nov 17, 2026 Decision stated in the source Substantially Equivalent Source facts
Decision Substantially Equivalent
Received 2012-02-08
Specialty Neurology
Decision code SESE
Clearance type Traditional Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Keep following this market Carry a company or product code into your watchlist for ongoing matching and a weekly brief.
Nihon Kohden Corp.
14 days free. No card required. Then $49/month when you choose to subscribe.
Device classifications FDA dataset: Nov 9, 2026
Last successful check: Nov 21, 2026
Source classifications may change.
510(k) clearances FDA dataset: Nov 9, 2026
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
Recall records FDA dataset: Nov 19, 2026
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Keep this research moving. Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.
Start a 14-day free trial ↗